Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Operating activities:
Net income (loss)	$ (357,735)	$ 797,119
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	57,000	61,633
Amortization of debt discount	50,452	0
Amortization of debt issuance costs	150,992	0
Stock compensation expense	88,595	2,111
Change in fair value of derivative instruments	18,286	0
Gain from the sale of product line	(499,529)	0
Benefit from deferred income taxes	0	(277,489)
Change in assets and liabilities
Accounts receivable	(65,357)	(271,455)
Notes receivable	8,892	67,597
Inventories	(443,098)	(37,832)
Marketable securities	(12,570)	0
Prepaid expenses	(47,979)	(539,899)
Deposits and other assets	351,412	(70,035)
Accounts payable	(160,980)	(257,443)
Accrued expenses	(22,479)	154,679
Income taxes	54,841	0
Net cash used in operating activities	(829,257)	(371,014)
Cash flows from investing activities:
Purchase of property and equipment	(60,991)	(9,526)
Proceeds from the sale of product line	500,000	0
Net cash provided by (used in) investing activities	439,009	(9,526)
Cash flows from financing activities:
Proceeds of notes payable	0	850,000
Payment of notes payable	(766,807)	(101,946)
Issuance of vendor notes	0	9,000
Payment of vendor notes	(1,000)	(190,526)
Proceeds from line of credit	4,547,857	2,612,208
Repayment of line of credit	(4,695,508)	(2,548,474)
Payment of financing costs	0	15,056
Debt discount for deriviative instruments	0	57,512
Deferred offering costs	(767,507)	0
Cash acquired in merger	4,498,430	0
Member distribution	0	(170,445)
Distributions to shareholder	(364,406)	0
Net cash provided by financing activities	2,451,059	532,385
Net increase in cash	2,060,811	151,845
Cash and cash equivalents, beginning of period	364,608	66,491
Cash and cash equivalents, end of period	2,425,419	218,336
Supplemental Disclosure of Cash Flow Information
Cash paid for interest	206,341	78,268
Non-cash transactions
Conversion of notes payable to common stock	250,000	0
Conversion of accounts payable to notes payable	$ 0	$ 124,204